Recipient Epidemiology and Donor Evaluation Study-III | NHLBI Trans-Omics for Precision Medicine Skip to main content

Recipient Epidemiology and Donor Evaluation Study-III

Short Name
REDS-III_Brazil
Institution(s)
Vitalant Research Institute
Type of Omics
WGS
Approx. Sample Size 2809
Disease/Phenotype
sickle cell disease
Starting Phase
Phase 2
dbGaP ID
TOPMed Accession #
Please see this TOPMed Project's Parent Studies.
Omics Center(s) Phase 2
Baylor College of Medicine Human Genome Sequencing Center
Specify the TOPMed Phase for the Omics Center(s) selected above
Ph 5.4-5.5; 6 backfill
Phases Involved
2
Populations
Brazilian
PI
Co-PI
NIH Program Officer
Phenotype Liaison
Steering Committee Representatives
P&P primary
Project
REDS-III_Brazil
Released
No
Back to top